Vaxart, Inc. 50,000,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • June 14th, 2024 • Vaxart, Inc. • Biological products, (no disgnostic substances) • New York
Vaxart, Inc., Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 50,000,000 shares of common stock (the “Shares”), par value $0.0001 per share, of the Company (the “Common Stock”). The amount and form of the Shares to be purchased by the Underwriters is set forth opposite its name on Schedule A hereto
